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Abstract
Mesenchymal stem cells (MSCs) are a rare heterogeneous population of multipotent cells that can be isolated
from many different adult and fetal tissues. They exhibit the capacity to give rise to cells of multiple lineages and
are defined by their phenotype and functional properties, such as spindle-shaped morphology, adherence to
plastic, immune response modulation capacity, and multilineage differentiation potential. Accordingly, MSCs
have a wide range of promising applications in the treatment of autoimmune diseases, tissue repair, and
regeneration. Recent studies have shed some light on the exact identity and native distribution of MSCs, whereas
controversial results are still being reported, indicating the need for further review on their definition and origin.
In this article, we summarize the important progress and describe some of our own relevant work on the
developmental definition of MSCs.
Introduction
In the original definition, the term ‘‘MSC’’ can representeither mesenchymal stromal cells or mesenchymal stem
cells. The term mesenchymal stromal cells may not be an ac-
curate description, as stromal cells only represent connective
tissue cells rather than functional cells. However, the term
mesenchymal stem cells is not sufficiently descriptive either
and has been questioned by Bianco et al. (2008), as cells
derived from nonmesenchymal tissues have exhibited com-
parable properties to MSCs. Nevertheless, the term has
gained such global usage that it has become the most
accepted description. MSCs or MSC-like cells are widely
distributed throughout tissues, including bone marrow,
muscle, fat, hair follicles, tooth root, placenta, dermis, peri-
chondrium, articular cartilage, umbilical cord, lung, and
liver (Alsalameh et al., 2004; Arai et al., 2002; Forbes et al.,
2002; Friedenstein et al., 1970; Fukuchi et al., 2004; Giangreco
et al., 2002; Jahoda et al., 2003; Lee et al., 2004a, 2004b;
Pierdomenico et al., 2005; Schultz et al., 1981; Toma et al.,
2001; Williams et al., 2010; Young et al., 2001; Zuk et al.,
2002). They were initially identified by their potential to
differentiate upon induction, into several mesenchymal
lineages such as bone and cartilage (Bianco and Gehron,
2000; Makino et al., 1999; Pittenger et al., 1999).
MSCs are comprised of a heterogeneous population of
undifferentiated, committed, and lineage-primed cells, with
the ability to ‘‘home’’ upon engraftment. As a type of adult
stem cell, they show extensive proliferation, produce differ-
entiated progeny, and functionally repair damaged tissues
(Phinney et al., 1999). Since the disclosure of good immune
tolerance and safety following MSC transplantation, clinical
trials have been conducted to investigate the feasibility of the
treatment of large bone defects, genetic bone disease such as
osteogenesis imperfecta, cotransplantation with hematopoi-
etic stem cells (HSCs) for the repair of hematopoietic stroma
and graft-versus-host disease (De et al., 2003; Fang et al.,
2009; Haleem et al., 2010; Joo et al., 2010; Le et al., 2005; Zhou
et al., 2010). Although the previous definition of MSCs has
become inadequate, due to tremendous progress achieved on
the biology of MSCs, novel developmental theories have
been proposed including the HSC origin of MSCs, the neural
crest origin of MSCs, the pericyte origin of MSCs, and the
avascular tissue origin of MSCs.
In this article we summarize the current findings on the
definition of MSCs and give an overview of the recent ad-
vances in the ontogeny, characterization by surface markers,
and microRNA (miRNA) profiles of MSCs. We also outline
some interesting results from our latest work that may help
unravel the origin of MSCs from the avascular tissue.
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The Ontogeny of MSCs
MSCs were defined as mesenchymal-derived and by their
functionality to generate a number of differentiated progeny
and to self-renew. Alhough they were originally identified
from bone marrow (BM) in the early 1970s by Friedenstein
et al (1970), it is still not a well-characterized stem/progenitor
cell population. It is generally accepted that MSCs may not
only be isolated from the BM but also frommany other tissues
(Table 1). Recently, more evidences on the origin of MSCs
have been brought forward in an attempt to reveal the
ontogeny and physiological role of these cells.
In this regard, a few studies have suggested HSCs as an
origin of MSC-like cells, as HSCs were able to differentiate
into perivascular cells under an inductive condition and
generated fibroblasts and their precursors (Ebihara et al.,
2006; Hess et al., 2004; LaRue et al., 2006; Visconti et al.,
2006). In his review, Ogawa et al. (2006) raised an hypothesis
that fibroblasts and myofibroblasts in many organs and
tissues are derived from HSCs, but there was no further
experimental evidence to support this theory after 2006.
Recent findings have demonstrated that neural crest-
derived cells exist in the adult BM and stem cells derived
from BM can differentiate into neural cells ( Jiang et al., 2002;
Nagoshi et al., 2008). To confirm the relevance of these un-
expected findings in vivo, Takashima and Morikawa dem-
onstrated that neural crest was one of the developmental
origins of MSCs in the adult BM, because the earliest wave of
MSCs in the embryonic trunk was generated from Sox1+
neuroepithelium and cells derived from the neural crest
possessed the similar characteristics with MSCs from other
origins (Morikawa et al., 2009; Takashima et al., 2007).
Similarly, Miller raised the theory that MSCs may arise from
both the neural and nonneural tissues (Miller, 2007).
Probably the most interesting and so far the best accepted
hypothesis is the pericyte origin of MSCs. The pericytes and
smooth muscle cells have been reported to be able to trans-
differentiate not only into the adult leydig cells, but also into
osteocytes, adipocytes, chondrocytes, smooth muscle cells,
and neural lineages (Davidoff et al., 2009; Doherty et al.,
1998; Dore-Duffy et al., 2006; Farrington-Rock et al., 2004;
Meyrick and Reid, 1978). The pericytes also expressed MSC
markers, such as CD146, NG2, and PDGF-Rb (Franklin et al.,
1990; Ozerdem et al., 2001; Schwab and Gargett, 2007). A
remarkable work conducted by Crisan and his colleagues
established both the in situ and ex vivo links between human
adult MSCs and pericytes (Crisan et al., 2008). The findings
demonstrated that cells positive for MSC markers also ex-
pressed pericyte markers, and CD146 + pericytes (negative
for CD34, CD45, and CD56) had the same multipotent ca-
pacity as MSCs (Crisan et al., 2008). Both MSCs and pericytes
could migrate in response to digested extracellular matrix
and other chemotactic stimuli, which could recruit MSCs to a
regenerative microenvironment (Crisan et al., 2008). It is
further reported that pericytes from human fetal, perinatal,
and adult organ natively expressed MSC markers and pos-
sessed similar multilineage differentiation potential (Corselli
et al., 2010). BMSCs expressed pericyte marker 3G5, and
these cells are located in the vascular niche, where BMSCs
may also provide mesenchymal elements (Kang et al., 2010;
Khan et al., 2010).
However, the most recent findings are challenging the
current notion, in which MSC-like cells can be derived from
avascular and aneural tissue, for example, from the inter-
vertebral disc (IVD). The IVD is a roughly cylindrical
structure, comprised of a well-hydrated central nucleus
pulposus (NP), an annulus fibrosus (AF) consisting of firm
but flexible collagenous lamellae that surrounds the NP,
and cartilaginous endplates forming an interface between
disc and adjacent vertebrae (Zhou et al., 2008). Recently, a
few studies have detected the existence of MSC-like cells in
the degenerated human IVD and quadrupedal IVD. These
cells possessed similar immunophenotype and differentia-
tion capacity to BMSCs (Bianco et al., 2010; Henriksson
et al., 2009; Risbud et al., 2007). To date, whether MSC-like
cells are present in healthy human IVD has not been
documented. To provide direct evidence of MSCs from
the normal IVD, we have isolated cells from the IVD of
healthy Rhesus monkeys, which can serve as an ideal model
resembling humans in their genetic phylogeny, almost up-
right biomechanics, and the notochordal cell disappearance
and the prevalence of disc degeneration associated with
aging (Kramer et al., 2002; Pennisi, 2007; Stoeckelhuber
et al., 2005; Watanabe, 1983). We found that the IVD-
derived MSC-like cells express MSC markers such as CD44,
CD90, CD146, and CD166, and are negative for CD34 and
CD45. Furthermore, these cells demonstrate MSC-like dif-
ferentiation capacities in vitro and are capable of generating
IVD-like tissue in vivo. Furthermore, the cells show the self-
renewal property by maintaining colony-forming ability,
multidifferentiation potential, and transplantability after
serials of cell divisions in vivo. In parallel, other studies have
reported that pericytes are not the only cell type that acts as
a source of MSCs (Feng et al., 2011). The study demon-
strated that genetically marked pericytes can differentiate
into odontoblasts in vivo and suggested the existence of
nonpericyte-derived MSCs (Feng et al., 2011). Furthermore,
the ratio of distribution was also described depending
on the extent of vascularity and kinetics of growth (Feng
et al., 2011).
Table 1. Multiple Tissues Types Where MSCs
Have Been Isolated
Tissue origin Publications
Muscle Schultz, 1981; Med. Sci. Sports Exerc.
Young et al., 2001; Anat. Rec.
Fat Zuk et al., 2002; Mol. Biol. Cell
Hair follicels Jahoda et al., 2003; Exp. Dermatol.
Tooth root Pierdomenico et al., 2005;
Transplantation
Placenta Fukuchi et al., 2004; Stem Cells
Dermis Toma et al., 2001; Nat. Cell Biol.
Perichondrium Arai et al., 2002; J. Exp. Med.
articular cartiliage Williams et al., 2010; PloS One
Alsalameh et al., 2004; Arthritis Rheum.
Umbilical cord Lee et al., 2004; Blood
Lung Giangreco et al., 2002; Am. J. Pathol.
Liver Forbes et al., 2002; J. Pathol.
Synovium Sakaguchi et al., 2005; Arthritis Rheum.
Periodontal
ligament
Seo et al., 2004; Lancet
Tendon Bi et al., 2007; Nat. Med.
Pancreas Sordi et al., 2010; Stem Cells
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Another crucial origin of MSCs is through the epithelial to
mesenchymal transition (EMT), which is a fundamental
process causing epithelial cells to lose their polarization and
specialized junctional structure, undergo cytoskeleton reor-
ganization and to acquire morphological and functional
features of mesenchymal-like cells. A series of studies by
Rubio et al. (2008), Limbert (2010), and Battula et al. (2010)
found that EMT-derived cells shared many properties with
MSCs, including the phenotype and functionality, as the
EMT-derived cells expressed MSC markers and could dif-
ferentiate into osteoblasts, adipocytes, and chondrocytes.
However, not all epithelial cells can undergo EMT during
development. Sordi and colleagues (2010) have revealed the
pancreatic MSCs (PMSCs) are derived from BM by cell lin-
eage tracing, rather than from the CD133 + duct cells through
EMT.
Thus, the origin and ontogeny of adult MSCs are still
complex and somewhat contradictory scenarios. Never-
theless, most findings support the overall conclusion that
MSCs may originate from the perivascular sites, which is
dominant in postnatal tissues. The other sources of MSCs
may be related to neural crest and HSCs, and also the
shielding tissues,which can maintain the protal properties to
adult age, or the generation from transition.
Surface Markers of MSCs
Great efforts have been made to develop a cell-surface
antigen profile for better purification and identification of
MSCs. Indeed, several common mesenchymal markers have
been identified for the characterization of MSCs including
stro-1, CD13, CD29, CD44, CD73, CD105, and CD106, and it
is generally agreed that MSC do not express CD31, CD34,
CD45, and CD117 (Kucia et al., 2005; Rolf et al., 2008). Flow
cytometry analysis demonstrated the basic multiple markers
used to assess noncultured MSCs, such as CD105, CD166,
CD90, CD44, CD29, CD73, and CD9 (Halfon et al., 2011).
Changes in surface expression of MSC markers have been
reported with cell growth and passage number. The ex-
pression of ITGA11, CD146, and CD106 on BMSCs decreases
with increased passage number, but the expression of CD9
increases during the process, and a high level of CD9 is
found in fibroblasts (Covas et al., 2008; Halfon et al., 2011). In
adipose-derived MSCs (ASCs), the expression of stromal
markers such as CD29, CD44, CD90, and CD166 changes
during culture (Mitchell et al., 2006). Epigenetically, MSCs
sequentially lose their myogenic, adipogenic, chondrogenic,
osteogenic,and fibroblastic progenitor potential during
growth and aging, probably indicating the hierarchical
mechanism of MSC fate decisions (Sarugaser et al., 2009).
Recent studies have highlighted CD146 as a putative MSC
marker for its association with the origin and aging of MSCs.
This marker has been specifically suggested as one of the
MSC markers in endometrium (Schwab and Gargett, 2007;
Schwab et al., 2008). Other independent studies have also
verified that CD146 + cells possess comparable phenotype
and differentiation potential to MSCs and represent potential
use in the regulation of HSCs (Covas et al., 2008; Sorrentino
et al., 2008). In addition, CD146 + pericytes were reported to
retain myogenicity, exhibit tripotency at the clonal level, and
express MSCs markers (Crisan et al., 2009). Importantly, a
subset of MSCs expressing CD146 in combination with other
new markers such as NOTCH3 or ITGA11 displayed en-
hanced colony-forming capacities, and the CD146/NOTCH3
double-positive MSCs possessed enhanced potential to dif-
ferentiate into other lineages, such as adipocytes and osteo-
cytes (Kaltz et al., 2010). When comparing CD146 expression
in MSCs and fibroblasts, most of the MSCs expressed CD146
but only around 5% of fibroblasts did, which is in line with
the results from Covas reporting that 73% of BM-derived
MSC and 2% of skin fibroblasts expressed CD146 (Covas
et al., 2008; Kaltz et al., 2010). Interestingly, our own un-
published work has shown that the MSC-like cells isolated
from the IVD tissue also expressed CD146 (Fig. 1A) and the
CD146 + subsets possessed multidifferentiation capacity (Fig.
1B–E).
An additional specific surface marker for MSCs is CD271.
It defines a subset of cells with high proliferative, clonogenic,
and multipotential differentiation ability in adult BM (Quirici
et al., 2002). Amnion mesenchymal cells (AMCs) and chorion
mesenchymal cells (CMCs) have been reported to pheno-
typically and functionally resemble BMSCs, and the CD271 +
fraction of AMCs and CMCs possess stronger stem cell po-
tential (Soncini et al., 2007). Comparision of the CD271bright
FIG. 1. CD146 expression
and multidifferentiation
potentials of MSC-like cells
isolated from the IVD (NP)
tissue. (A) Flow cytometry
analysis for the surface
expression of CD146;
adipogenic differentiation
was observed using Oil Red
O staining (B), chondrogenic
differentiation was observed
using Alican blue staining
(C), and osteogenic
differentiation was observed
using Alkaline Phosphatase
staining (D) and Alizarin
Red S (E).
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MSCs with the CD271dim MSCs from BM, only the positive
subsets maintained the capacity to form colonies and coex-
pressed common MSC markers (Bu¨hring et al., 2007). Other
studies observed that the CD271 + fraction of MSCs have
been reported to generate higher numbers of colonies and
may be the most homogenous faction and better suitable for
expansion ( Jarocha et al., 2008). In addition, the CD271 +
fraction of MSCs can improve the engraftment of CD133 +
HSCs in transplantation, with immunosuppressive and
lympho-hematopoietic engraftment-promoting properties
(Kuc¸i et al., 2010). Compared with the bulk of ASCs, the
CD271 + fraction of ASCs demonstrated a greater differenti-
ation potential toward adipocytes, osteoblasts, and
chondrocyte-like cells (Quirici et al., 2010). The CD271 +
fraction of ASCs from aged mice possessed proliferation and
differentiation potentials almost equal to the ASCs from
young mice even though the differentiation potentials
showed a tendency to decrease (Yamada et al., 2010). In
osteoarthritic tissue, the CD45-/CD271+ MSCs abundantly
existed in the trabecular bone cavity and displayed aging-
related loss of proliferation ( Jones et al., 2010). Osteoarthritic
synovial membranes contained more CD271 + cells than
healthy joints, and spontaneous cartilage repair tissue con-
tained cells positive for CD271 antigen, suggesting the in-
volvement of CD271 antigen in spontaneous cartilage repair
(Hermida-Go´mez et al., 2011).
Other cell surface molecules such as TNAP, FZD9, and
Stro-4 and side population of MSCs are also focused and
deemed as promising MSC markers (Battula et al., 2008;
Gronthos et al., 2009; Kobayashi et al., 2008; Sobiesiak et al.,
2010). Among all these potential MSC markers, we recom-
mend that CD146 and CD271 may be the most useful
markers, although their function remains to be elucidated.
Cell migration, cytoskeletal response and signaling pathway
stimulation assays currently used to analyze MSC membrane
proteins may prove to be useful in investigating and study-
ing the functions of those MSC markers.
Micro-RNA Profiles of MSCs
Gene expression profiling has fundamentally enhanced
our understanding and approach to characterizing MSCs
identifying potential biomarkers, or determining key mole-
cules regulating biological processes. MiRNAs are likely to
be invovled in gene regulation during the early stages of
differentiation, which may play an important role in deter-
mining cell fate (Table 2). Although the detailed role of each
miRNA in stem cell biology remains to be analyzed, un-
derstanding how miRNAs affect stem cell behavior will ad-
vance our definition of MSCs. Previous studies have
demonstrated that miRNA-9 might be involved in regulating
neuronal differentiation of MSC through the Notch signaling
pathway ( Jing et al., 2011). In adipogenic differentiation, the
senescence-associated miRNAs, such as miRNA-369-5p and
miRNA-371, were identified as antagonistic upstream regu-
lators of adipogenic differentiation in MSCs. The adipogenic
potential of MSCs was impaired by miRNA-369-5p but
highly increased by miRNA-371. However, the adipogenic
differentiation process itself required the downregulation of
miRNA-369-5p while miRNA-371 was not affected (Bork
et al., 2010). Another potential regulator in ASC adipogenic
differentiation is miRNA-21, which mediated ASCs through
the modulation of TGF-beta signaling. Overexpressing
miRNA-21 decreased its target TGFBR2. The adipogenic
differentiation process was accompanied with increased
level of miRNA-21 and decreased level of TGFBR2. In con-
trast, inhibiting miRNA-21 resulted in increased TGFBR2
level in ASCs, accompanied by decreased adipogenic dif-
ferentiation (Kim et al., 2009a, 2011). In osteogenic differen-
tiation, miRNA-196a regulates osteogenic differentiation of
ASCs through its target HOXC8; the overexpression of miR-
196a led to increased osteogenic differentiation, whereas the
inhibition of miR-196a resulted in decreased osteogenesis
(Kim et al., 2009b). mi-RNA-26a, - 141, and - 200a were also
reported to be involved in the modulation of osteogenic
differentiation of MSCs (Itoh et al., 2009; Luzi et al., 2008).
Furthermore, miRNA have been reported to be implicated in
a chondrocytic differentiation-related expression pattern of
MSCs. The reduction of miRNA-140 expression in osteoar-
thritic cartilage may contribute to abnormal gene expression
pattern of osteoarthritis (Miyaki et al., 2009). mi-RNA-199a
was found to adversely regulate early chondrocyte differ-
entiation through the Smad pathway, as the miRNA-199a
significantly inhibited Smad1/Smad4-mediated transactiva-
tion of target genes, and overexpression of Smad1 com-
pletely compensated miRNA-199a-mediated repression of
early chondrogenesis (Lin et al., 2009). There are some ad-
ditional potential miRNAs that have been recently reported
to be involved in the chondrogenesis of MSCs, such as the
hsa-miR-130b, hsa-miR-152, and hsa-miR-26b (Han et al.,
2010).
Table 2. MicroRNAs Reported to be Involved
in the Regulation of MSC Fates
MicroRNAs Functionality Publications
MiRNA-9 Neurnal
differentiation
Jing et al., 2011;
Neuroreport
MiRNA-369-5p Adipogenic
differentiation
Bork et al., 2010;
J. Cell Physiol.
MiRNA-371 Adipogenic
differentiation
Bork et al., 2010;
J. Cell Physiol.
MiRNA-21 Adipogenic
differentiation
Kim et al., 2009a;
Stem Cells
Kim et al., 2011;
J. Cell Physiol.
MiRNA-335-5p Osteogenic
differentiation
Zhang et al., 2011;
J. Bone Miner. Res.
MiRNA-196a Osteogenic
differentiation
Kim et al., 2009b;
J. Bone Miner. Res.
MiRNA-26a Osteogenic
differentiation
Luzi et al., 2008;
J. Bone Miner. Res.
MiRNA-141 Osteogenic
differentiation
Itoh et al., 2009;
J. Biol. Chem.
MiRNA-200a
MiRNA-140 Chondrogenic
differentiation
Miyaki et al., 2009;
Arthritis Rheum.
MiRNA-199a Chondrogenic
differentiation
Lin et al., 2009;
J. Biol. Chem.
MiRNA-130b Chondrogenic
differentiation
Han et al., 2010; Int.
J. Mol. Med.
MiRNA-152
MiRNA-26b
MiRNA-221 Chondrogenic
differentiation
Kim et al., 2010;
J. Biol. Chem.
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Summary
Up to now, the ontogeny of MSCs has been best explained
by the characterization of pericytes from multiple human
organs, which are myogenic, multidifferentiatial, and exhibit
the features of MSCs. Recent findings suggested that the
origin of MSCs is not only perivascular, but can be extended
to other mesodermal lineages (such as IVD cells), neu-
roectodermal lineages (neurons, astrocytes, and oligoden-
drocytes) and endodermal lineages (hepatocytes, pancreatic
cells). Such findings would question the previous definition
for MSCs with mesenchymal origin, as cells derived from
other tissues can bear the same properties.
As a result, based on the in vitro evidence, the MSC system
may be distinct from other classic stem cell systems (such as
hematopoietic or neural), in that the stem cell microenvi-
ronment varies considerably while supporting the same stem
cell type with similar properties. Further work on the mo-
lecular phenotypes such as cell surface markers and critical
miRNA patterns of MSCs from various origins, may be
helpful in clarifying the ontogeny as well as the functional
potentials of these cells.
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